Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Bifidobacterium (mixed) for Allergies (Respiratory): Scientific Evidence Synopsis

Bifidobacterium species, a group of probiotics commonly found in the human gut, have been investigated for their potential role in modulating immune responses and reducing symptoms of respiratory allergies, such as allergic rhinitis and asthma. The rationale behind their use is based on the ability of certain strains to influence the balance between Th1 and Th2 immune responses, potentially reducing allergic inflammation.

Several clinical trials and meta-analyses have examined the effects of mixed probiotic formulations containing Bifidobacterium on respiratory allergies. Some studies suggest that these probiotics may reduce the severity of allergic symptoms or decrease the frequency of episodes, particularly in children. However, the results are inconsistent; not all studies have demonstrated significant benefits, and heterogeneity in probiotic strains, dosages, and study designs complicates interpretation.

A 2015 meta-analysis in Pediatrics found modest benefits of probiotics (including Bifidobacterium) for preventing eczema but inconclusive results for respiratory allergies. More recent studies, such as those published in Allergy and Clinical and Experimental Allergy, suggest potential symptom improvement, but overall, the evidence remains preliminary and insufficient for strong clinical recommendations.

In summary, there is some scientific evidence—mostly from small or heterogeneous studies—that mixed Bifidobacterium probiotics may provide mild benefit for respiratory allergies, but the quality and consistency of evidence warrant cautious interpretation. Large, high-quality RCTs are needed to clarify their role.

More about Bifidobacterium (mixed)
More about Allergies (respiratory)

Other ingredients used for Allergies (respiratory)

Other health conditions supported by Bifidobacterium (mixed)

Products containing Bifidobacterium (mixed)